HEALTHCARE GLOBAL ENTERPRISES Financial Statement Analysis
|
||
|
The Revenues of HEALTHCARE GLOBAL ENTERPRISES have increased by 12.80% YoY .
The Earnings Per Share (EPS) of HEALTHCARE GLOBAL ENTERPRISES has increased by 63.98 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
HEALTHCARE GLOBAL ENTERPRISES Last 5 Annual Financial Results
[BOM: 539787|NSE : HCG]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Operating Income | ₹1,908 Cr | ₹1,691 Cr | ₹1,395 Cr | ₹1,009 Cr | ₹1,092 Cr |
| Expenses | ₹1,583 Cr | ₹1,411 Cr | ₹1,160 Cr | ₹887 Cr | ₹923 Cr |
| Operating Profit (Excl OI) | ₹325 Cr | ₹280 Cr | ₹235 Cr | ₹122 Cr | ₹169 Cr |
| Other Income | ₹21 Cr | ₹32 Cr | ₹16 Cr | ₹21 Cr | ₹10 Cr |
| Interest | ₹109 Cr | ₹104 Cr | ₹98 Cr | ₹119 Cr | ₹138 Cr |
| Depreciation | ₹174 Cr | ₹163 Cr | ₹158 Cr | ₹159 Cr | ₹148 Cr |
| Profit Before Tax | ₹68 Cr | ₹45 Cr | ₹88 Cr | ₹-229 Cr | ₹-119 Cr |
| Profit After Tax | ₹41 Cr | ₹18 Cr | ₹39 Cr | ₹-221 Cr | ₹-125 Cr |
| Consolidated Net Profit | ₹48 Cr | ₹29 Cr | ₹54 Cr | ₹-193 Cr | ₹-107 Cr |
| Earnings Per Share (Rs) | ₹3.46 | ₹2.11 | ₹3.87 | ₹-15.43 | ₹-12.03 |
| PAT Margin (%) | 2.17 | 1.04 | 2.79 | -21.91 | -11.48 |
| ROE(%) | 4.99 | 2.06 | 5.16 | -43.32 | -29.68 |
| ROCE(%) | 12.79 | 11.69 | 15.17 | -9.66 | 1.65 |
| Total Debt/Equity(x) | 0.83 | 0.47 | 0.47 | 0.73 | 1.91 |
Key Financials |
||
| Market Cap | : | ₹ 7,402.8 Cr |
| Revenue (TTM) | : | ₹ 2,043.6 Cr |
| Net Profit(TTM) | : | ₹ 61.2 Cr |
| EPS (TTM) | : | ₹ 4.4 |
| P/E (TTM) | : | 121.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HEALTHCARE GLOBAL ENTERPRISES | 3.8% | 8.9% | 46.2% |
| APOLLO HOSPITALS ENTERPRISE | -0.4% | -8.5% | 7.6% |
| MAX HEALTHCARE INSTITUTE | 12.6% | -2.1% | 49.5% |
| GLOBAL HEALTH | -0.7% | -2.1% | -16.3% |
| FORTIS HEALTHCARE | -3% | -14.4% | 44.6% |
| NARAYANA HRUDAYALAYA | 3.2% | -0.5% | 0.9% |
| ASTER DM HEALTHCARE | -2.4% | -9.7% | 9.4% |
| DR LAL PATHLABS | -1.7% | -8.7% | 15.7% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 6.2% | -1.4% | 43.1% |
HEALTHCARE GLOBAL ENTERPRISES Revenues
[BOM: 539787|NSE : HCG]
| Y-o-Y | 12.80 % |
| 5 Yr CAGR | 14.96 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹1,908 Cr | 12.80 | |
| Mar2023 | ₹1,691 Cr | 21.27 | |
| Mar2022 | ₹1,395 Cr | 38.21 | |
| Mar2021 | ₹1,009 Cr | -7.61 | |
| Mar2020 | ₹1,092 Cr | - | |
HEALTHCARE GLOBAL ENTERPRISES Operating Profit
[BOM: 539787|NSE : HCG]
| Y-o-Y | 16.09 % |
| 5 Yr CAGR | 17.81 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹325 Cr | 16.09 | |
| Mar2023 | ₹280 Cr | 19.27 | |
| Mar2022 | ₹235 Cr | 92.07 | |
| Mar2021 | ₹122 Cr | -27.56 | |
| Mar2020 | ₹169 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 2.90 % |
| 5 Yr CAGR | 2.48 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 17.05% | 2.90 | |
| Mar2023 | 16.57% | -1.66 | |
| Mar2022 | 16.85% | 39.03 | |
| Mar2021 | 12.12% | -21.60 | |
| Mar2020 | 15.46% | - | |
HEALTHCARE GLOBAL ENTERPRISES Profit After Tax
[BOM: 539787|NSE : HCG]
| Y-o-Y | 64.08 % |
| 5 Yr CAGR | Positive |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹48 Cr | 64.08 | |
| Mar2023 | ₹29 Cr | -45.38 | |
| Mar2022 | ₹54 Cr | Positive | |
| Mar2021 | ₹-193 Cr | Negative | |
| Mar2020 | ₹-107 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 108.65 % |
| 5 Yr CAGR | Positive |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 2.17 % | 108.65 | |
| Mar2023 | 1.04 % | -62.72 | |
| Mar2022 | 2.79 % | Positive | |
| Mar2021 | -21.91 % | Negative | |
| Mar2020 | -11.48 % | - | |
HEALTHCARE GLOBAL ENTERPRISES Earnings Per Share (EPS)
[BOM: 539787|NSE : HCG]
| Y-o-Y | 63.98 % |
| 5 Yr CAGR | Positive |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹3.46 | 63.98 | |
| Mar2023 | ₹2.11 | -45.48 | |
| Mar2022 | ₹3.87 | Positive | |
| Mar2021 | ₹-15 | Negative | |
| Mar2020 | ₹-12 | - | |
HEALTHCARE GLOBAL ENTERPRISES Return on Capital Employed (ROCE)
[BOM: 539787|NSE : HCG]
| Y-o-Y | 9.41 % |
| 5 Yr CAGR | 66.86 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 12.79% | 9.41 | |
| Mar2023 | 11.69% | -22.94 | |
| Mar2022 | 15.17% | Positive | |
| Mar2021 | -9.66% | Negative | |
| Mar2020 | 1.65% | - | |
HEALTHCARE GLOBAL ENTERPRISES Share Price vs Sensex
| Current Share Price | : | ₹531.1 |
| Current MarketCap | : | ₹ 7,402.8 Cr |
| Updated EOD on | : | Feb 04,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HEALTHCARE GLOBAL ENTERPRISES | 3.8% |
8.9% |
46.2% |
| SENSEX | 2.7% |
0.8% |
9.7% |
HEALTHCARE GLOBAL ENTERPRISES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 3.4% | -5.3% | 26.3% |
| S&P BSE MIDSMALLCAP | 3.3% | -11% | 8.6% |
| S&P BSE SMALL CAP | 1.5% | -8.4% | 9.2% |
| S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
No NSE index found
You may also like the below Video Courses
FAQ about HEALTHCARE GLOBAL ENTERPRISES Financials
How the annual revenues of HEALTHCARE GLOBAL ENTERPRISES have changed ?
The Revenues of HEALTHCARE GLOBAL ENTERPRISES have increased by 12.80% YoY .
How the Earnings per Share (EPS) of HEALTHCARE GLOBAL ENTERPRISES have changed?
The Earnings Per Share (EPS) of HEALTHCARE GLOBAL ENTERPRISES has increased by 63.98 % YoY .
Check out Intrinsic Value of Peers of HEALTHCARE GLOBAL ENTERPRISES
Compare Stock Analytics of Peers of HEALTHCARE GLOBAL ENTERPRISES
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs GLOBAL HEALTH LTD
FORTIS HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs GLOBAL HEALTH LTD
FORTIS HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
